Sumereau-Dassin E, Bourebia J
Haemostasis. 1985;15(3):182-8. doi: 10.1159/000215142.
Thrombocytopoietin seems to be only partially responsible for the regulation of platelet production. We determined precisely the differences between a second thrombocytopoiesis-stimulating factor (TSF2), and thrombocytopoietin (TSF1) and erythropoietin (Epo). Fractionation was carried out, first on a DEAE-cellulose phosphate column and then on a Sephadex G-75 column. Thrombocytopoietic activity in the various fractions was assessed using 75Se-methionine platelet incorporation into normal recipients. Epo concentrations were determined using a radioimmunoassay. We showed that the apparent molecular weight of TSF2 is 14,000 daltons. It differs from TSF1 (48,000 daltons) and from Epo (39,000 daltons). For doses of 8-12 mU Epo/rat, found in whole serum injected, no effect on thrombocytopoiesis was found. On the contrary, a significant effect (p less than 0.01) was found when the same quantities of Epo present in the Sephadex G-75 F4' fraction were injected (2-10 mU/rat). TSF2 can be separated from TSF1 and Epo, using biochemical techniques.
血小板生成素似乎仅部分负责血小板生成的调节。我们精确测定了第二种血小板生成刺激因子(TSF2)与血小板生成素(TSF1)和促红细胞生成素(Epo)之间的差异。首先在DEAE - 纤维素磷酸柱上进行分级分离,然后在葡聚糖G - 75柱上进行分级分离。使用将75硒 - 蛋氨酸掺入正常受体血小板的方法评估各组分中的血小板生成活性。使用放射免疫测定法测定Epo浓度。我们发现TSF2的表观分子量为14,000道尔顿。它与TSF1(48,000道尔顿)和Epo(39,000道尔顿)不同。对于注射的全血清中发现的8 - 12 mU Epo/大鼠的剂量,未发现对血小板生成有影响。相反,当注射葡聚糖G - 75 F4'组分中存在的相同量的Epo(2 - 10 mU/大鼠)时,发现有显著影响(p小于0.01)。使用生化技术可以将TSF2与TSF1和Epo分离。